Neovascularization, Pathologic [clinicaltrials_resource:3c52fe25e0fd581001f2f486aa0d1839]
Branch Vein Occlusion Study [clinicaltrials:NCT00000162]Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis [clinicaltrials:NCT01731262]clinicaltrials:NCT01813045clinicaltrials:NCT01837160Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases [clinicaltrials:NCT02448732]
condition [clinicaltrials_vocabulary:condition]
Krypton-Argon Regression of Neovascularization Study (KARNS) [clinicaltrials:NCT00000153]Macular Photocoagulation Study (MPS) [clinicaltrials:NCT00000158]Branch Vein Occlusion Study [clinicaltrials:NCT00000162]Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration [clinicaltrials:NCT00001615]Screening for Studies on Retinovascular Diseases [clinicaltrials:NCT00001733]Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization [clinicaltrials:NCT00004430]Fluocinolone Implant to Treat Macular Degeneration [clinicaltrials:NCT00008515]Phase II/III Study of Anti-VEGF in Neovascular AMD [clinicaltrials:NCT00021736]Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00051129]A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration [clinicaltrials:NCT00090532]A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00090623]Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System [clinicaltrials:NCT00100087]Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease [clinicaltrials:NCT00102115]Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00138632]Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. [clinicaltrials:NCT00211484]clinicaltrials:NCT00242580A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00251459]TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration [clinicaltrials:NCT00260403]Macugen for Histoplasmosis [clinicaltrials:NCT00272766]clinicaltrials:NCT00275821clinicaltrials:NCT00284089Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration [clinicaltrials:NCT00288561]A Pilot Study for the Treatment of Iris Neovascularization With Macugen [clinicaltrials:NCT00295828]clinicaltrials:NCT00304954Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT) [clinicaltrials:NCT00305630]clinicaltrials:NCT00327470clinicaltrials:NCT00331864Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy [clinicaltrials:NCT00344617]PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization [clinicaltrials:NCT00358345]PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV) [clinicaltrials:NCT00359008]clinicaltrials:NCT00363168A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00363714]Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV) [clinicaltrials:NCT00370786]clinicaltrials:NCT00379795Lucentis (Ranibizumab) for Eales' Disease [clinicaltrials:NCT00384449]Avastin for CNV Secondary to Pattern Dystrophy [clinicaltrials:NCT00391144]clinicaltrials:NCT00395057Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. [clinicaltrials:NCT00395551]Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [clinicaltrials:NCT00403156]Intravitreal Bevacizumab in Agioid Streaks [clinicaltrials:NCT00406250]
condition browse [clinicaltrials_vocabulary:condition-browse]
Krypton-Argon Regression of Neovascularization Study (KARNS) [clinicaltrials:NCT00000153]Macular Photocoagulation Study (MPS) [clinicaltrials:NCT00000158]Branch Vein Occlusion Study [clinicaltrials:NCT00000162]Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration [clinicaltrials:NCT00001615]Screening for Studies on Retinovascular Diseases [clinicaltrials:NCT00001733]Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization [clinicaltrials:NCT00004430]Fluocinolone Implant to Treat Macular Degeneration [clinicaltrials:NCT00008515]Phase II/III Study of Anti-VEGF in Neovascular AMD [clinicaltrials:NCT00021736]Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00051129]A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration [clinicaltrials:NCT00090532]A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00090623]Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System [clinicaltrials:NCT00100087]Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease [clinicaltrials:NCT00102115]Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00138632]Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. [clinicaltrials:NCT00211484]clinicaltrials:NCT00242580A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00251459]TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration [clinicaltrials:NCT00260403]Macugen for Histoplasmosis [clinicaltrials:NCT00272766]clinicaltrials:NCT00275821clinicaltrials:NCT00284089Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration [clinicaltrials:NCT00288561]A Pilot Study for the Treatment of Iris Neovascularization With Macugen [clinicaltrials:NCT00295828]clinicaltrials:NCT00304954Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT) [clinicaltrials:NCT00305630]clinicaltrials:NCT00327470clinicaltrials:NCT00331864Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy [clinicaltrials:NCT00344617]PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization [clinicaltrials:NCT00358345]PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV) [clinicaltrials:NCT00359008]clinicaltrials:NCT00363168A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT00363714]Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV) [clinicaltrials:NCT00370786]clinicaltrials:NCT00379795Lucentis (Ranibizumab) for Eales' Disease [clinicaltrials:NCT00384449]Avastin for CNV Secondary to Pattern Dystrophy [clinicaltrials:NCT00391144]clinicaltrials:NCT00395057Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. [clinicaltrials:NCT00395551]Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [clinicaltrials:NCT00403156]Intravitreal Bevacizumab in Agioid Streaks [clinicaltrials:NCT00406250]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Neovascularization, Pathologic [clinicaltrials_resource:3c52fe25e0fd581001f2f486aa0d1839]
Bio2RDF identifier
3c52fe25e0fd581001f2f486aa0d1839
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3c52fe25e0fd581001f2f486aa0d1839
identifier
clinicaltrials_resource:3c52fe25e0fd581001f2f486aa0d1839
title
Neovascularization, Pathologic
@en
type
label
Neovascularization, Pathologic [clinicaltrials_resource:3c52fe25e0fd581001f2f486aa0d1839]
@en
Neovascularization, Pathologic